Suppurative and necrotic conditions of lower respiratory tract

J10_NECROTIC

pleural empyema: The presence of pus in the thoracic cavity, between the visceral and parietal pleura. [database_cross_reference: NCIT:P378]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J85-J86 Cause of death: ICD-10 — J85-J86 2 out of 7 registries used, show all original rules.	1840
4. Check minimum number of events None	1840
5. Include endpoints J10_LUNGNECROSIS J10_ABSCLUNGPNEUMO J10_ABSCMEDIASTINUM J10_PYOTHORAX	2016
6. Filter based on genotype QC (FinnGen only)	2016

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	J10_NECROTIC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_LUNGNECROSIS\|J10_ABSCLUNGPNEUMO\|J10_ABSCMEDIASTINUM\|J10_PYOTHORAX
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J8[5-6]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J8[5-6]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Suppurative and necrotic conditions of lower respiratory tract based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18004	5053	12664
Only index persons	13269	3969	9300
Unadjusted period prevalence (%)
Whole population	0.29	0.14	0.35
Only index persons	0.29	0.15	0.36
Median age at first event (years)
Whole population	60.87	62.52	60.16
Only index persons	60.11	61.41	59.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2016	550	1466
Unadjusted period prevalence (%)	0.52	0.19	0.65
Median age at first event (years)	63.12	58.83	64.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1805: Matched controls
18049

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J18.9

ICD-10 Finland

Pneumonia, unspecified

8.2

323.0

1165

3285

J86.9

ICD-10 Finland

Pyothorax without fistula

+∞

323.0

1116

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

14.3

284.3

517

491

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

31.9

268.5

361

140

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

+∞

256.5

240

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

+∞

220.4

207

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.7

200.9

711

1842

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

+∞

200.8

189

J01MA14

ATC

moxifloxacin; systemic

7.8

197.2

511

870

J01FF01

ATC

clindamycin; systemic

4.4

169.8

856

3097

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

6.6

169.2

498

991

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.7

154.1

437

816

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

11.3

154.0

306

319

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

145.9

1131

5683

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

12.8

145.2

270

244

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

97.6

138.5

152

GD1AD

NOMESCO Finland

Thorax CT examination

8.3

118.7

281

391

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.5

117.4

391

866

J01MA12

ATC

levofloxacin; systemic

3.6

105.7

605

2227

ZXD05

NOMESCO Finland

Urgent procedure

3.0

98.0

803

3790

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.3

95.8

404

1126

GAC46

NOMESCO Finland

Partial decortication of pleura

204.8

94.3

J86.09

ICD-10 Finland

Pyothorax with fistula

+∞

90.4

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

11.8

88.7

169

156

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

41.4

78.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

77.5

484

1829

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

21.5

75.8

113

J94.8

ICD-10 Finland

Other specified pleural conditions

12.5

73.1

135

116

GAC96

NOMESCO Finland

Other operation on pleura

360.7

70.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.4

68.5

389

1357

5100A

ICD-9 Finland

Empyema, With fistula

+∞

68.1

TGA30

NOMESCO Finland

Thoracocentesis

24.1

65.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.5

59.0

227

560

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

8.9

58.7

129

154

J85.3

ICD-10 Finland

Abscess of mediastinum

+∞

58.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.2

58.6

350

1253

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

58.2

607

3061

JN4BD

NOMESCO Finland

Extensive body CT

3.3

58.2

330

1136

R4110

NOMESCO Finland

Physiotherapy

2.4

52.3

582

3002

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

50.5

498

2405

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

36.8

50.0

WX892

NOMESCO Finland

Monitored bed care

3.6

50.0

250

775

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

48.3

290

1030

R03BB04

ATC

tiotropium bromide; inhalant

2.9

46.4

313

1202

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

44.1

218

667

GAC47

NOMESCO Finland

Endoscopic partial decortication of pleura

157.2

44.0

GAA97

NOMESCO Finland

Other thoracoscopic drainage procedures on pleura

157.2

44.0

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.3

43.2

172

435

C03CA01

ATC

furosemide; systemic

2.1

42.3

671

3984

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.5

42.0

214

670

Z2446

NOMESCO Finland

Social worker

3.8

41.5

188

534

WX872

NOMESCO Finland

Intensive care

3.9

39.3

174

484

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

39.3

343

1523

N02AA05

ATC

oxycodone; systemic

2.5

38.4

358

1646

Z3226

NOMESCO Finland

Physiotherapist

2.3

38.0

405

1993

R06.0

ICD-10 Finland

Dyspnoea

2.1

36.3

505

2800

H02AB06

ATC

prednisolone; systemic

1.9

36.0

867

5932

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

35.3

394

1975

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

34.9

874

6036

J86

ICD-10 Finland

Pyothorax

+∞

34.5

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

11.8

34.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

34.3

371

1826

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

34.0

396

2018

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.6

33.0

158

468

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

12.4

32.6

GAA31

NOMESCO Finland

Thoracoscopy

23.6

32.3

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.4

32.0

305

1406

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.7

31.6

112

252

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.5

31.0

156

481

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

31.0

688

4499

Z2221

NOMESCO Finland

Medical doctor

2.0

30.5

523

3112

GDC00

NOMESCO Finland

Lobectomy of lung

12.0

30.0

N02AX02

ATC

tramadol; systemic, rectal

1.8

29.9

798

5531

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.4

29.8

153

479

N05BA01

ATC

diazepam; systemic, rectal

2.4

29.2

282

1303

N05CF01

ATC

zopiclone; oral

1.8

28.8

615

3944

N03AX16

ATC

pregabalin; oral

2.0

28.5

430

2425

WX730

NOMESCO Finland

Conventional respirator

6.7

28.3

112

51399

ICD-8 Finland

Abscess of lung

+∞

28.2

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.4

28.1

169

N05AH04

ATC

quetiapine; oral

2.2

28.0

308

1515

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.0

27.7

172

614

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.7

27.3

125

357

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.7

26.7

122

348

TGC00

NOMESCO Finland

Bronchial lavation

4.6

26.6

211

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

26.5

288

1406

R81

ICPC

Pneumonia

4.3

26.2

101

247

ZXE00

NOMESCO Finland

One hour or less

1.7

26.2

709

4874

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.0

26.1

125

N05AH03

ATC

olanzapine; systemic

3.4

26.0

134

420

B01AB05

ATC

enoxaparin; parenteral

1.8

25.8

558

3565

R03AC02

ATC

salbutamol; inhalant

1.7

25.8

852

6206

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.8

25.6

Z3231

NOMESCO Finland

Registered nurse

1.8

25.3

528

3325

N05AA02

ATC

levomepromazine; systemic

3.5

25.2

122

364

R50.9

ICD-10 Finland

Fever, unspecified

2.2

25.2

296

1495

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.3

25.2

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

25.0

374

2089

GAC43

NOMESCO Finland

Total decortication of pleura

253.5

24.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.1

24.5

144

494

N05CD07

ATC

temazepam; oral

2.2

24.4

276

1371

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

24.3

115

337

A28

ICPC

Limited function/disability NOS

2.1

24.1

316

1669

A02BC02

ATC

pantoprazole; systemic

1.7

24.1

1109

8802

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.8

24.1

166

635

5130A

ICD-9 Finland

Abscess of lung and mediastinum, Abscess of lung

+∞

24.0

N05AH02

ATC

clozapine; systemic

6.3

23.9

104

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.3

23.7

126

404

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.2

23.5

129

424

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

23.1

319

1720

JN4AD

NOMESCO Finland

Body CT examination

2.6

22.9

179

737

ZX120

NOMESCO Finland

Intravenous

2.4

22.6

205

911

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

22.5

212

962

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

22.4

377

2189

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

22.3

329

1818

R04.2

ICD-10 Finland

Haemoptysis

3.6

22.2

103

298

J47

ICD-10 Finland

Bronchiectasis

5.8

22.1

111

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

22.0

520

3383

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.1

22.0

219

51009

ICD-8 Finland

Empyema, UD

+∞

21.9

GAC40

NOMESCO Finland

Pleurodesis with decortication

222.5

21.6

N06AX11

ATC

mirtazapine; oral

1.7

21.3

527

3471

130

Kela drug reimbursment

Malignant tumour

2.3

21.2

205

942

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

21.2

132

473

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

21.1

284

N07BB01

ATC

disulfiram; oral

3.1

20.5

117

395

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

20.4

136

508

AA1AD

NOMESCO Finland

CT of head and brain

1.8

20.1

441

2792

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.2

20.0

194

WX882

NOMESCO Finland

High dependency care

4.1

20.0

199

J86.01

ICD-10 Finland

Empyema with pleuro-cutaneous fistula

+∞

19.8

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.2

19.8

5862

FHL

Decortication (removal of visceral or parietal pleura)

74.3

19.7

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

19.6

309

1746

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

19.6

119

420

N05BA04

ATC

oxazepam; oral

1.8

19.5

411

2564

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

19.5

297

J96.1

ICD-10 Finland

Chronic respiratory failure

4.2

19.4

185

N02BE01

ATC

paracetamol; systemic, rectal

1.7

19.4

1441

12600

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.9

19.0

123

449

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

19.0

221

1103

A06AD11

ATC

lactulose; oral

1.9

18.9

303

1720

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.3

18.8

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

7.6

18.4

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.8

18.3

TK800

NOMESCO Finland

Hemodialysis

4.1

18.2

182

GBB00

NOMESCO Finland

Tracheostomy

6.3

18.1

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

16.7

17.9

GAW97

NOMESCO Finland

Other thoracoscopic operation on chest wall, pleura and diaphragm

67.3

17.7

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

17.7

109

389

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

17.7

335

2010

J94.2

ICD-10 Finland

Haemothorax

14.7

17.6

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

17.5

277

WX110

NOMESCO Finland

Local anesthesy

1.5

17.4

1071

8773

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.6

17.4

J96.0

ICD-10 Finland

Acute respiratory failure

5.7

17.1

N06AB03

ATC

fluoxetine; oral

2.1

17.1

199

992

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.0

16.8

171

N03AG01

ATC

valproic acid; systemic, rectal

2.6

16.6

124

494

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.6

16.6

126

GWE00

NOMESCO Finland

Reoperation for deep haemorrhage in thoracic surgery

40.5

16.3

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

14.4

16.3

GAC00

NOMESCO Finland

Biopsy of pleura

14.4

16.3

J43.9

ICD-10 Finland

Emphysema, unspecified

4.6

16.2

125

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.5

16.1

130

WX250

NOMESCO Finland

Intercostal blockade

16.9

16.1

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

6.0

16.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

16.1

168

800

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.8

16.0

179

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

16.0

162

758

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

16.0

176

856

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

15.9

149

670

N06AB04

ATC

citalopram; systemic

1.7

15.9

342

2129

P01AB01

ATC

metronidazole; oral, rectal

1.6

15.8

572

4108

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

7.4

15.7

WX704

NOMESCO Finland

Intubation

2.4

15.7

138

605

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

15.7

227

1235

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.3

15.7

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.3

15.6

150

686

K22.3

ICD-10 Finland

Perforation of oesophagus

85.8

15.6

R03DA04

ATC

theophylline; systemic, rectal

2.4

15.4

135

589

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

14.9

15.4

N05BA02

ATC

chlordiazepoxide; systemic

3.5

15.2

203

ZXA00

NOMESCO Finland

Right side

1.6

15.2

467

3213

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.8

15.1

107

Z51.5

ICD-10 Finland

Palliative care

2.4

15.0

135

598

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.3

14.9

131

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

14.8

472

3273

J02AC03

ATC

voriconazole; systemic

32.0

14.8

R4190

NOMESCO Finland

Nutritional therapy

3.3

14.8

229

K08.3

ICD-10 Finland

Retained dental root

2.3

14.8

139

628

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

14.7

312

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.5

14.6

204

XG410

NOMESCO Finland

Flow-volume spirometry

2.9

14.6

337

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.0

14.6

299

WX725

NOMESCO Finland

Noninvasive ventilation

2.7

14.6

101

386

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

5.3

14.6

N05AX08

ATC

risperidone; systemic

2.2

14.5

159

769

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

5.9

14.5

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

14.5

314

1957

J01XX08

ATC

linezolid; systemic

9.5

14.4

S97

ICPC

Chronic ulcer skin

2.5

14.3

118

500

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.7

14.3

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.0

14.3

146

C03DA01

ATC

spironolactone; oral

1.9

14.3

211

1157

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

8.7

14.2

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

14.2

114

477

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

14.2

215

WX002

NOMESCO Finland

Sedation and analgesia

1.7

14.0

344

2222

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

13.9

504

3598

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

7.9

13.9

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

13.8

382

R02

ICPC

Shortness of breath/dyspnoea

1.9

13.8

201

1094

C07AB07

ATC

bisoprolol; oral

1.5

13.6

837

6699

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

13.6

256

1525

WX402

NOMESCO Finland

General anaesthesia

1.8

13.5

260

1559

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

13.4

247

J01MA02

ATC

ciprofloxacin; systemic

1.5

13.4

672

5152

N05AF03

ATC

chlorprothixene; systemic

3.6

13.2

168

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

13.2

195

1070

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.4

13.2

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

13.1

101

413

WW200

NOMESCO Finland

Immunization

3.4

13.1

195

WW500

NOMESCO Finland

Blood transfusion

2.8

13.1

321

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

11.0

13.0

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

13.0

224

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

13.0

142

691

F10.24

ICD-10 Finland

Alcohol depence active use

4.4

12.9

107

RS221

NOMESCO Finland

4.8

12.9

J01DB01

ATC

cefalexin; oral

1.5

12.9

1326

11717

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.9

12.8

S27.1

ICD-10 Finland

Traumatic haemothorax

7.2

12.8

UJC12

NOMESCO Finland

Flexible oesophagoscopy

6.5

12.6

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

12.6

352

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.6

12.6

164

B01AA03

ATC

warfarin; systemic

1.6

12.6

409

2834

51099

ICD-8 Finland

+∞

12.5

N06AA12

ATC

doxepin; systemic

2.4

12.5

108

469

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

12.4

113

503

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

12.4

489

3546

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

6.9

12.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

4.4

12.4

102

P15

ICPC

Chronic alcohol abuse

3.2

12.4

210

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

12.4

351

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.2

12.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.9

12.2

S01.0

ICD-10 Finland

Open wound of scalp

2.1

12.2

147

745

J94.9

ICD-10 Finland

Pleural condition, unspecified

7.0

12.1

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.3

12.1

181

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.3

12.0

105

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.1

12.0

215

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

11.9

600

4576

A03

ICPC

Fever

1.8

11.8

221

1312

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

6.2

11.8

J93.8

ICD-10 Finland

Other pneumothorax

7.7

11.6

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

23.0

11.6

J01FA06

ATC

roxithromycin; oral

1.5

11.5

609

4682

A46

ICD-10 Finland

Erysipelas

1.7

11.5

255

1594

R03BB01

ATC

ipratropium bromide; inhalant

2.4

11.4

424

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.1

11.4

195

J01AA02

ATC

doxycycline; systemic

1.4

11.3

1261

11130

N07BA03

ATC

varenicline; oral

2.5

11.3

376

ZXA05

NOMESCO Finland

Left side

1.5

11.3

427

3057

H02AB02

ATC

dexamethasone; systemic

1.9

11.2

166

910

SPAT1255

SPAT

Intravenous administration of medicine

2.1

11.2

129

640

R53

ICD-10 Finland

Malaise and fatigue

1.6

11.2

315

2099

H02AB07

ATC

prednisone; oral

1.7

11.2

238

1469

JAH00

NOMESCO Finland

Laparotomy

3.1

11.2

192

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

25.2

11.1

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

6.1

11.1

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.0

11.0

110

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

43.6

10.9

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

5.7

10.9

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.8

10.9

R13

ICD-10 Finland

Dysphagia

2.2

10.8

113

539

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

10.7

369

2581

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.2

10.7

170

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.4

10.7

R82

ICPC

Pleurisy/pleural effusion

28.2

10.7

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.1

10.7

193

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

10.6

239

1500

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

5.8

10.6

TK810

NOMESCO Finland

Hemofiltration

7.0

10.6

J85.0

ICD-10 Finland

Gangrene and necrosis of lung

+∞

10.4

I50.0

ICD-10 Finland

Congestive heart failure

1.9

10.4

150

816

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

10.4

292

C45.0

ICD-10 Finland

Mesothelioma of pleura

12.1

10.3

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

10.3

269

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

5.8

10.3

GDB10

NOMESCO Finland

Wedge resection of lung

18.9

10.3

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

10.2

216

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

10.2

183

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

10.1

610

4783

N05AC02

ATC

thioridazine; oral

3.7

10.1

114

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

11.3

10.1

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

10.0

105

502

SPAT1254

SPAT

Administration of medicine

1.7

9.9

239

1527

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.6

9.9

126

N03AE01

ATC

clonazepam; systemic

2.2

9.9

101

477

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

12.2

9.8

RD210

NOMESCO Finland

4.0

9.8

P72

ICPC

Schizophrenia

3.9

9.8

102

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.7

9.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

9.8

179

1052

W19

ICD-10 Finland

Unspecified fall

1.8

9.7

164

941

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

9.7

130

686

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

13.4

9.7

GAC20

NOMESCO Finland

Excision or destruction of lesion of pleura

55.3

9.6

OAB43

SPAT

0.4

9.6

1080

J93.9

ICD-10 Finland

Pneumothorax, unspecified

6.8

9.6

EBA00

NOMESCO Finland

Extraction of tooth

1.4

9.6

485

3671

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.9

9.5

100

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

10.1

9.5

RS220

NOMESCO Finland

4.3

9.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

4.3

9.5

N05AF05

ATC

zuclopenthixol; systemic

4.8

9.5

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

100.5

9.4

R95

ICPC

Chron obstructive pulmonary disease

2.7

9.4

238

ZY010

NOMESCO Finland

Hospital outpatient

2.6

9.4

271

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

17.6

9.4

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

9.4

134

725

GAB96

NOMESCO Finland

Other thoracotomy

+∞

9.4

J86.0

ICD-10 Finland

Pyothorax with fistula

+∞

9.4

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

9.4

132

711

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.9

9.4

X57

ICD-10 Finland

Unspecified privation

3.1

9.4

160

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

9.4

126

668

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.2

9.4

149

Z72.0

ICD-10 Finland

Tobacco use

3.2

9.4

149

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

9.3

341

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.0

9.3

181

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

9.2

108

F05.9

ICD-10 Finland

Delirium, unspecified

3.2

9.2

151

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

13.7

9.2

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

9.1

198

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

9.1

700

5699

P16

ICPC

Acute alcohol abuse

3.5

9.1

115

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.2

9.0

142

K22.2

ICD-10 Finland

Oesophageal obstruction

4.9

9.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

9.0

119

627

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

18.7

8.9

J15.8

ICD-10 Finland

Other bacterial pneumonia

5.8

8.9

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.1

8.9

155

V03AA01

ATC

3.3

8.9

133

N04AA02

ATC

biperiden; systemic

3.5

8.9

117

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

8.9

330

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

8.8

340

K92.0

ICD-10 Finland

Haematemesis

2.7

8.7

225

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

14.1

8.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.9

8.7

180

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

8.6

395

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.3

8.6

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.3

8.6

131

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.1

8.6

142

J80

ICD-10 Finland

Adult respiratory distress syndrome

8.3

8.6

R03AC12

ATC

salmeterol; inhalant

2.2

8.6

410

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

8.5

460

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

5.0

8.5

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

8.5

435

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

8.5

391

GWW96

NOMESCO Finland

Other reoperation in thoracic surgery

27.6

8.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

8.4

104

533

L04AA13

ATC

leflunomide; oral

3.1

8.4

145

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

8.3

116

623

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

8.3

210

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.5

8.3

J98.1

ICD-10 Finland

Pulmonary collapse

5.5

8.3

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

8.3

157

936

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

8.2

191

B01AB10

ATC

tinzaparin; parenteral

1.9

8.2

109

576

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.4

8.2

109

N05AX12

ATC

aripiprazole; systemic

2.6

8.2

216

N17.8

ICD-10 Finland

Other acute renal failure

4.4

8.1

N05BA12

ATC

alprazolam; oral

1.8

8.1

144

842

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

8.1

143

R4120

NOMESCO Finland

Occupational therapy

2.0

8.1

104

543

R84

ICPC

Malignant neoplasm bronchus/lung

8.2

8.1

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

6.8

8.1

Z72.1

ICD-10 Finland

Alcohol use

3.6

8.1

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.4

8.0

111

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

8.0

257

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

8.0

160

970

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.3

8.0

N03AF01

ATC

carbamazepine; oral, rectal

2.1

8.0

458

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

7.3

8.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.3

8.0

E87.6

ICD-10 Finland

Hypokalaemia

2.6

7.9

215

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

7.9

115

628

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.4

7.9

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

7.9

512

Z71.8

ICD-10 Finland

Other specified counselling

1.5

7.8

319

2304

TJD20

NOMESCO Finland

Change of gastrostomy tube

10.8

7.8

OAA67

SPAT

0.3

7.8

490

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

7.8

208

1366

WZC30

NOMESCO Finland

Teaching

1.6

7.8

206

1346

A41.8

ICD-10 Finland

Other specified sepsis

3.0

7.8

142

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

7.7

460

E86

ICD-10 Finland

Volume depletion

2.7

7.7

195

S18

ICPC

Laceration/cut

1.3

7.7

643

5264

FWC00

NOMESCO Finland

Reoperation for deep infection in surgery of heart and major thoracic vessels

15.1

7.7

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.3

7.7

P18

ICPC

Medication abuse

7.4

7.7

N06AB10

ATC

escitalopram; oral

1.5

7.7

243

1660

N05AD01

ATC

haloperidol; systemic

2.3

7.6

292

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

8.1

7.6

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

8.1

7.6

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.2

7.6

325

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

7.6

106

571

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

25.1

7.6

1240

FHL

Bronchoscopy

3.7

7.6

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.2

7.5

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

7.5

260

1810

ED1AA

NOMESCO Finland

Mandipular X-ray examination

6.2

7.5

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.2

7.5

117

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.4

7.5

J01CF05

ATC

flucloxacillin; systemic

2.2

7.5

318

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.7

7.5

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.7

7.5

A07AA02

ATC

nystatin; oral

2.0

7.5

521

X58

ICD-10 Finland

Exposure to other specified factors

1.6

7.5

196

1280

N06AB06

ATC

sertraline; oral

1.8

7.5

133

778

B01AB04

ATC

dalteparin; parenteral

2.1

7.5

414

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.3

7.5

107

S42.0

ICD-10 Finland

Fracture of clavicle

2.5

7.5

222

R03BA02

ATC

budesonide; inhalant

1.5

7.5

242

1660

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.4

7.4

102

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

80.4

7.4

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

7.7

7.4

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.3

7.4

R28

ICPC

Limited function/disability (R)

3.6

7.4

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

7.3

372

ZY000

NOMESCO Finland

Hospital inpatient

4.7

7.3

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.2

7.3

GDW97

NOMESCO Finland

Other thoracoscopic operation on lung

+∞

7.3

51010

ICD-8 Finland

+∞

7.3

GAA15

NOMESCO Finland

Insertion of pleural drainage tube by resection of rib

+∞

7.3

J86.02

ICD-10 Finland

Empyema with broncho-pleural-cutaneous fistula

+∞

7.3

JCA08

NOMESCO Finland

Endoscopic removal of foreign body from oesophagus

10.9

7.3

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.3

7.2

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.8

7.2

161

GDD00

NOMESCO Finland

Pneumonectomy

15.8

7.2

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.0

7.2

127

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

7.2

179

1155

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.8

7.2

WX130

NOMESCO Finland

Interpleural anesthesia

30.1

7.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

7.1

110

613

N18.0

ICD-10 Finland

End-stage renal disease

3.5

7.1

N03AX09

ATC

lamotrigine; oral

2.3

7.1

275

J04AB02

ATC

rifampicin; systemic

3.6

7.1

GDA20

NOMESCO Finland

Excision of lesion of lung

12.1

7.1

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

10.1

7.0

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.0

297

2158

A02BC01

ATC

omeprazole; systemic

1.4

7.0

423

3279

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

7.0

124

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.0

7.0

124

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

7.0

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

7.0

109

613

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

4.9

7.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

7.0

155

970

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.3

6.9

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.3

6.9

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

13.8

6.9

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.8

6.9

148

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.9

6.9

J01DA01

ATC

[U] cefalexin; systemic

1.3

6.9

962

8439

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

3.8

6.9

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.8

6.9

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

8.3

6.8

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

5.0

6.8

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

6.8

J98.5

ICD-10 Finland

Diseases of mediastinum, not elsewhere classified

9.3

6.8

SPAT1227

SPAT

Substance abuse rehabilitation

5.3

6.8

A04AA01

ATC

ondansetron; systemic, rectal

1.9

6.7

509

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.2

6.7

105

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

6.7

159

1011

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

6.7

455

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.3

6.7

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

6.7

111

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.7

6.7

161

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.6

6.7

SPAT1265

SPAT

Breathalyser

3.8

6.7

L28

ICPC

Limited function/disability (L)

1.5

6.7

237

1660

N05BE01

ATC

buspirone; oral

2.6

6.7

187

XG466

NOMESCO Finland

Sleep oxymetry

2.2

6.6

297

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

6.4

6.6

L04AX01

ATC

azathioprine; systemic

2.1

6.6

345

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

6.6

245

N06AA04

ATC

clomipramine; systemic

3.5

6.6

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

3.1

6.6

107

UGC02

NOMESCO Finland

Rigid bronchoscopy

12.3

6.6

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.0

6.6

412

WX722

NOMESCO Finland

PEEP

1.9

6.5

484

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

10.1

6.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

6.5

230

1608

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.4

6.5

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.8

6.5

142

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

6.5

158

A01

ICPC

Pain general/multiple sites

1.8

6.5

101

566

F31

ICD-10 Finland

Bipolar affective disorder

4.1

6.5

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.1

6.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

6.5

201

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

6.5

110

634

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

6.5

261

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

6.2

6.5

J93

ICD-10 Finland

Pneumothorax

70.1

6.4

5842

FHL

Operative thoracostomy

70.1

6.4

P99

ICPC

Psychological disorders other

2.8

6.4

137

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.6

6.4

177

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

6.4

376

2896

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

4.1

6.4

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.3

6.4

N05AN01

ATC

lithium; oral

2.9

6.4

131

I50.1

ICD-10 Finland

Left ventricular failure

1.9

6.4

531

R06AE07

ATC

cetirizine; oral

1.3

6.4

534

4348

S22.3

ICD-10 Finland

Fracture of rib

1.8

6.3

109

633

Z72.2

ICD-10 Finland

Drug use

6.6

6.3

A11CC03

ATC

alfacalcidol; systemic

2.5

6.3

180

N05AB01

ATC

dixyrazine; systemic

3.1

6.3

105

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.2

6.3

292

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

9.3

6.3

R60.0

ICD-10 Finland

Localized oedema

1.6

6.3

162

1053

5841

FHL

Trocar rhostomy

18.1

6.3

GA4BT

NOMESCO Finland

Cathetrisation of pleural cavity with X-ray guidance

+∞

6.3

P19

ICPC

Drug abuse

4.3

6.2

J15.4

ICD-10 Finland

Pneumonia due to other streptococci

26.8

6.2

C07AA05

ATC

propranolol; systemic

1.5

6.2

225

1583

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.0

6.2

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

7.0

6.2

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

7.0

6.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

6.2

194

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.5

6.2

194

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

6.2

139

871

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

6.3

6.2

P01BA02

ATC

hydroxychloroquine; oral

1.8

6.1

102

587

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

6.1

512

4161

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

6.1

235

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.6

6.1

160

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.0

6.1

108

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

6.1

304

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

12.6

6.1

T74.1

ICD-10 Finland

Physical abuse

3.3

6.1

N06AX05

ATC

trazodone; oral

2.7

6.1

137

J18

ICD-10 Finland

Pneumonia, organism unspecified

4.4

6.0

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

6.7

6.0

GDA10

NOMESCO Finland

Biopsy of lung

10.0

6.0

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

10.0

6.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

6.0

384

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.0

6.0

109

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

871

2396

5.64

311.90

2.9

2.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

360

206

21.06

307.65

1.6

1.4

e6/l

44882.5

75147.9

0.68

231

121

(3012441) Differential panel - Pleural fluid

343

207

19.76

307.65

1.6

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

258

140

20.99

307.65

1.4

1.3

u/l

27.4

12.4

5.21

242

128

(3036782) Glucose [Moles/volume] in Pleural fluid

334

186

21.32

307.65

1.5

1.4

mmol/l

4.5

6.6

11.80

281

176

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

410

384

13.15

307.65

1.8

1.5

—

(3045788) Cell count panel - Pleural fluid

321

180

21.02

307.65

1.7

1.5

—

(3035880) pH of Pleural fluid

233

103

25.45

307.65

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

393

235

20.53

307.65

1.6

1.4

e6/l

16647.6

1468.6

4.30

287

170

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

314

181

20.36

307.65

1.4

1.3

u/l

1814.9

318.3

5.23

295

175

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

491

626

10.05

307.65

3.1

2.7

—

(40768806) Pleura Pathology biopsy report

315

208

17.76

307.65

1.6

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

415

263

19.61

307.65

1.6

1.5

g/l

36.8

31.2

8.07

386

238

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

391

487

9.72

302.43

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

308

335

10.67

262.65

1.3

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

215

134

17.84

257.15

1.6

1.4

u/l

11.5

14.4

3.25

207

125

(3023368) Bacteria identified in Blood by Culture

1178

4925

4.35

231.92

7.7

4.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

493

1444

4.20

150.32

2.7

2.8

g/l

61.8

66.4

24.49

467

1323

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

717

2833

3.38

138.13

2.5

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

166

185

9.69

137.24

4.0

3.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

575

2004

3.62

134.80

3.5

4.2

u/l

225.5

246.8

2.79

556

1891

(3000494) Fungus identified in Specimen by Culture

539

1847

3.62

129.10

2.0

1.5

—

(3023419) Bacteria identified in Sputum by Culture

174

225

8.37

127.76

3.5

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

549

1980

3.44

120.50

2.4

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

543

1976

3.39

117.11

2.3

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

16.47

116.12

1.5

1.4

mmol/l

6.5

3.5

5.09

(3012095) Magnesium [Moles/volume] in Serum or Plasma

651

2724

3.05

109.91

5.7

3.4

mmol/l

0.8

8.13

617

2556

(42870588) Differential panel, method unspecified - Blood

1006

5367

2.75

106.50

9.6

5.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

532

2076

3.12

100.39

12.4

7.8

kpa

5.3

5.1

4.96

507

1972

(3027801) Oxygen [Partial pressure] in Arterial blood

532

2077

3.12

100.30

12.3

7.7

kpa

10.8

11.9

6.81

507

1974

(3003396) Base excess in Arterial blood by calculation

531

2074

3.12

100.00

12.4

7.8

mmol/l

2.1

1.1

5.55

461

1604

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

295

792

4.19

98.75

2.8

1.9

ug/l

2.0

2.4

0.17

270

693

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

12.87

98.06

1.6

1.4

34.8

67.3

7.71

(3022096) Basophils/100 leukocytes in Blood

1181

7073

2.62

95.23

10.3

6.1

0.6

0.7

8.53

1148

6616

(3019069) Monocytes/100 leukocytes in Blood

1204

7301

2.61

94.21

11.0

6.4

9.0

8.9

0.06

1170

6844

(3006504) Eosinophils/100 leukocytes in Blood

1197

7270

2.59

92.84

10.5

6.1

2.6

2.9

4.92

1164

6781

(3001604) Monocytes [#/volume] in Blood

1246

7714

2.61

92.80

9.9

5.8

e9/l

0.7

0.6

27.37

1092

6642

(3006315) Basophils [#/volume] in Blood

1247

7746

2.60

91.84

10.0

5.8

e9/l

0.0

1.62

1099

6679

(3002030) Lymphocytes/100 leukocytes in Blood

1210

7457

2.56

89.86

10.7

6.2

21.5

26.9

48.15

1175

6957

(3019198) Lymphocytes [#/volume] in Blood

1258

7910

2.57

89.26

10.4

5.9

e9/l

1.7

1.9

2.41

1116

6952

(3013115) Eosinophils [#/volume] in Blood

1267

7998

2.57

89.06

11.1

6.1

e9/l

0.2

0.61

1130

7016

(3014111) Lactate [Moles/volume] in Serum or Plasma

425

1554

3.20

88.61

10.7

7.4

mmol/l

1.3

1.4

1.65

405

1493

(3018010) Neutrophils/100 leukocytes in Blood

1192

7334

2.53

88.21

10.2

6.0

62.9

57.9

32.66

1154

6877

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1302

8353

2.58

87.96

9.9

6.4

umol/l

10.5

12.4

8.56

1264

7937

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

356

1191

3.42

85.68

2.0

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

536

2279

2.84

84.96

8.9

6.3

mmol/l

1.1

1.0

1.44

511

2121

(3042631) Mycobacterium sp identified in Specimen

149

253

6.28

84.83

3.4

2.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

436

1665

3.07

83.97

9.1

7.5

mmol/l

10.5

10.6

0.02

419

1577

(3019060) Gas panel - Arterial blood

355

1227

3.30

80.76

8.6

5.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

12.44

78.31

1.6

1.5

2.1

0.01

(3013650) Neutrophils [#/volume] in Blood by Automated count

1336

8948

2.46

77.83

17.3

9.0

e9/l

5.4

4.3

28.43

1201

7798

(46235355) HIV 1 and 2 tests - Meaningful Use set

488

2058

2.81

77.81

1.9

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

13.49

77.04

1.3

1.2

ug/l

226.1

66.5

0.84

(3024561) Albumin [Mass/volume] in Serum or Plasma

1117

6946

2.36

76.68

8.1

5.2

g/l

30.7

35.0

65.62

1066

6461

(3016502) Oxygen saturation in Arterial blood

458

1884

2.85

76.41

13.6

8.1

94.4

95.4

1.83

443

1812

(3000919) Neutrophils/100 leukocytes in Pleural fluid

13.06

74.56

1.4

1.3

56.3

26.6

6.08

(3000991) Gas panel - Venous blood

389

1512

2.95

71.68

12.8

8.7

—

(3033658) Prothrombin time (PT) actual/Normal

755

4063

2.37

71.14

7.7

4.2

83.5

85.7

1.74

738

3977

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

231

661

3.82

69.86

3.5

2.7

u/ml

0.3

0.76

120

376

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1131

7257

2.27

69.56

13.1

6.5

mmol/l

1.2

12.91

1072

6566

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

13.04

69.38

1.6

1.4

52.0

25.7

3.85

(3002173) Hemoglobin [Mass/volume] in Arterial blood

416

1715

2.80

68.43

14.4

8.6

g/l

115.8

122.6

8.75

404

1648

(3041918) Cholesterol [Moles/volume] in Pleural fluid

15.69

66.73

1.6

1.2

mmol/l

1.7

1.5

0.49

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

144

297

5.14

66.34

1.7

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

127

237

5.65

65.37

1.3

1.1

—

(3032080) INR in Blood by Coagulation assay

1094

7043

2.21

65.17

13.2

10.7

inr

1.3

0.04

305

1972

(40758558) Short blood count panel - Blood

714

3888

2.30

64.09

11.5

6.8

—

(3002032) Base excess in Venous blood by calculation

397

1666

2.72

62.64

5.6

3.8

mmol/l

1.9

2.0

0.09

325

1305

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

166

406

4.37

62.06

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

396

1668

2.71

61.97

5.7

3.8

kpa

6.0

5.8

1.30

377

1612

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

170

424

4.29

61.96

1.8

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

271

939

3.18

60.48

13.1

10.3

mmol/l

25.2

24.3

3.63

253

880

(3018677) aPTT in Platelet poor plasma by Coagulation assay

543

2693

2.39

59.94

2.7

2.1

30.7

30.1

1.64

530

2607

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1175

7965

2.14

59.04

13.5

7.3

mmol/l

1.2

10.75

1011

6703

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

126

263

5.04

57.16

1.8

1.5

—

(3018418) pH of Serum or Plasma

791

4661

2.15

56.86

7.1

4.3

7.4

0.69

162

913

(3014576) Chloride [Moles/volume] in Serum or Plasma

470

2231

2.44

56.86

13.2

7.2

mmol/l

103.5

104.3

2.86

463

2171

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

118

234

5.29

56.75

1.8

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

245

855

3.12

53.77

5.8

4.2

mmol/l

24.1

0.00

224

774

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

282

1079

2.88

52.48

13.1

8.4

mmol/l

26.2

24.7

6.96

276

1071

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

358

1548

2.60

52.47

2.7

2.2

g/l

0.2

5.54

325

1439

(44786800) Granulocytes/100 leukocytes in Body fluid

17.55

52.41

1.7

1.6

48.8

13.9

4.23

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

116

244

4.98

52.11

8.6

6.6

mg/l

11.6

11.7

0.09

107

227

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

131

6.65

51.76

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

414

1928

2.44

51.75

2.2

1.8

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

15.32

51.19

1.7

1.3

u/l

56.6

19.2

0.83

(3042010) Triglyceride [Moles/volume] in Pleural fluid

13.73

50.31

1.7

1.3

mmol/l

0.5

1.3

1.01

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

129

305

4.45

50.24

1.9

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

242

4.89

49.69

1.8

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

144

374

4.07

49.55

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

144

374

4.07

49.55

1.5

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

484

2462

2.27

49.12

3.2

2.6

g/l

2.1

2.3

7.36

452

2289

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

813

5051

2.02

48.83

4.7

3.3

u/l

61.5

36.4

0.69

771

4807

(3014891) Appearance of Pleural fluid

13.92

48.58

1.9

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1308

9613

2.03

48.21

10.7

5.1

mmol/l

7.0

6.9

1.34

1273

9061

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

462

2330

2.28

47.70

3.4

2.7

19.2

23.1

6.71

388

2001

(3022948) Iron [Moles/volume] in Serum or Plasma

506

2649

2.22

47.70

3.3

2.6

umol/l

9.7

12.9

21.53

471

2461

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

800

5004

1.99

46.58

3.4

2.6

u/l

54.7

57.5

0.72

760

4632

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

112

254

4.61

45.93

2.0

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

316

1367

2.56

45.87

5.0

3.1

kpa

4.9

4.6

1.20

303

1317

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

254

985

2.81

45.83

14.7

10.7

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

15.09

45.16

1.7

1.4

45.7

68.6

1.86

(3021589) Normoblasts [#/volume] in Blood

1000

6814

1.93

44.66

17.8

10.0

e9/l

0.0

0.28

806

5582

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

691

4161

2.01

44.37

2.7

2.2

mg/l

3.1

3.0

0.55

601

3539

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

581

3293

2.07

44.09

5.2

4.0

ng/l

559.0

774.8

0.27

498

2721

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

226

841

2.90

43.96

1.6

1.9

g/l

1.8

1.5

3.12

189

724

(1616796) Gas panel - Central venous blood

145

412

3.71

43.88

6.3

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

783

4999

1.93

41.79

4.0

2.6

—

(3002582) Erythrocytes [#/volume] in Urine

791

5068

1.92

41.76

4.0

3.4

e6/l

56.4

90.8

1.02

613

4012

(36304419) Bacteria [Presence] in Urine

715

4444

1.94

41.23

3.7

3.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

255

1045

2.65

41.13

1.7

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

272

1159

2.56

40.48

15.2

7.2

mmol/l

25.7

24.5

5.13

257

1077

(3005719) IgG [Mass/volume] in Serum or Plasma

279

1206

2.52

40.28

3.4

2.7

g/l

10.5

10.7

0.40

257

1105

(3030467) Casts [#/volume] in Urine by Automated count

728

4589

1.92

39.97

3.8

3.3

e6/l

0.8

0.5

0.58

558

3551

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

200

4.77

39.70

2.0

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

401

2066

2.17

38.43

3.2

2.6

2.0

1.8

2.52

365

1839

(3026782) Osmolality of Urine

566

3318

1.98

38.22

3.1

2.8

mosm/kgh2o

530.6

569.2

4.20

500

2836

(3009445) Proteinase 3 Ab [Units/volume] in Serum

189

689

2.92

38.02

1.6

1.5

u/ml

17.4

22.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

363

1826

2.20

36.81

3.1

2.9

umol/l

7.4

9.4

1.50

309

1616

(3028026) IgM [Mass/volume] in Serum or Plasma

231

956

2.60

36.35

2.3

1.8

g/l

1.3

1.4

0.13

208

874

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

137

5.41

36.18

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.41

36.04

2.2

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.51

35.95

4.2

3.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

125

374

3.50

34.93

2.5

2.2

g/l

124.0

130.2

1.68

280

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.30

34.86

2.2

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1498

12121

1.92

34.84

13.9

7.7

u/l

89.5

80.3

10.07

1459

11423

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

12.33

34.19

1.7

4.7

0.01

(3018095) Leukocytes [#/volume] in Urine

839

5742

1.79

33.95

4.8

3.9

e6/l

95.6

117.5

0.34

633

4274

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

242

1063

2.45

33.48

2.2

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

5.68

32.94

2.2

1.5

—

(3012501) Base excess in Blood by calculation

129

414

3.26

32.24

9.0

4.9

mmol/l

3.0

2.6

0.95

109

276

(3013290) Carbon dioxide [Partial pressure] in Blood

129

415

3.25

32.12

9.0

4.9

kpa

5.3

5.0

2.56

123

408

(3027315) Oxygen [Partial pressure] in Blood

129

415

3.25

32.12

9.0

4.9

kpa

8.3

8.5

0.56

123

407

(3037692) Legionella sp identified in Specimen by Organism specific culture

7.65

31.90

1.4

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

610

3851

1.84

31.85

3.7

2.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

13.23

31.45

1.0

1.2

u/l

18.6

24.3

0.34

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

540

3299

1.87

31.21

2.2

1.7

mg/l

1.6

1.4

0.83

465

2559

(3010421) pH of Blood

139

480

3.04

30.69

8.7

4.6

7.4

0.15

124

407

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

295

1465

2.19

30.50

3.4

2.5

u/l

38.3

38.7

0.02

261

1257

(3023183) Ammonium ion [Moles/volume] in Plasma

127

420

3.16

30.19

2.9

2.8

umol/l

41.1

35.3

0.35

106

350

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

244

1128

2.32

29.96

6.3

3.9

mmol/l

2.3

1.8

0.96

180

836

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

136

473

3.01

29.65

3.6

2.5

g/l

4.1

3.7

1.32

131

444

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

991

7314

1.70

29.21

5.8

4.2

—

(3037756) Immunofixation for Serum or Plasma

114

362

3.28

28.98

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

142

4.77

28.83

2.3

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

563

3558

1.81

28.79

3.2

2.7

e6/l

5.7

4.2

1.76

510

3151

(3009343) pH of Capillary blood

248

1175

2.27

28.69

6.5

3.9

7.4

0.64

144

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

250

1191

2.25

28.54

6.5

3.9

kpa

5.1

0.16

234

1104

(3017181) Myelocytes/100 leukocytes in Blood

269

1323

2.19

28.39

4.9

4.1

1.0

0.8

0.95

136

420

(3036481) Cortisol [Moles/volume] in Serum or Plasma

274

1362

2.17

28.14

2.5

2.2

nmol/l

386.8

369.8

0.52

257

1247

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

161

634

2.67

27.83

3.0

2.2

ug/l

510.2

575.3

0.11

155

603

(3015235) Bicarbonate [Moles/volume] in Capillary blood

135

487

2.90

27.56

4.0

3.3

mmol/l

24.6

24.9

0.23

115

423

(3015377) Calcium [Moles/volume] in Serum or Plasma

749

5209

1.70

26.94

4.7

3.4

mmol/l

2.3

4.08

680

4522

(44790047)

202

3.98

26.88

1.5

1.7

—

(44790049)

202

3.98

26.88

1.5

1.7

—

(44806118)

202

3.98

26.88

1.5

1.7

—

(44790048)

202

3.98

26.88

1.5

1.7

—

(4062490)

135

4.71

26.71

1.4

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1267

10142

1.67

26.08

5.8

4.4

e6/l

4701.7

1540.5

0.30

184

(3026008) Bacteria identified in Urine by Culture

641

4316

1.71

25.74

3.6

3.1

—

(3020891) Body temperature

171

728

2.47

25.13

10.8

4.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

290

1535

2.04

25.09

3.8

3.0

ng/l

279.0

228.6

0.89

268

1400

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

314

1710

1.99

25.08

3.0

4.2

ug/l

8.8

27.3

1.87

269

1438

(40767503) Oxygen content in Capillary blood by calculation

113

391

3.00

24.84

3.4

2.5

15.5

16.1

0.78

199

(3028626) Oxygen [Partial pressure] in Capillary blood

124

453

2.85

24.72

4.8

3.8

kpa

7.7

8.1

1.03

116

416

(3002179) Metamyelocytes/100 leukocytes in Blood

241

1199

2.15

24.55

4.7

4.0

0.6

0.20

106

299

(3004119) Hemoglobin [Mass/volume] in Venous blood

222

1069

2.21

24.55

5.7

3.2

g/l

121.2

128.8

4.55

214

1041

(3028192) IgG subclass 2 [Mass/volume] in Serum

133

4.54

24.37

1.4

1.3

g/l

2.7

3.0

0.61

(3024139) IgG subclass 3 [Mass/volume] in Serum

133

4.54

24.37

1.4

1.3

g/l

0.3

0.4

1.25

(3027135) IgG subclass 1 [Mass/volume] in Serum

133

4.54

24.37

1.4

1.3

g/l

6.7

6.9

0.19

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

10.96

24.24

1.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

105

354

3.07

24.15

3.4

2.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

319

1771

1.95

24.03

6.0

3.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

287

1540

2.01

23.83

2.0

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

286

1536

2.00

23.68

3.1

2.7

e9/l

75.8

69.3

1.53

208

1181

(3024928) Oxygen saturation in Venous blood

109

381

2.97

23.54

5.2

2.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

142

575

2.58

23.16

3.9

3.8

mg/l

94.6

65.8

0.47

117

457

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

142

575

2.58

23.16

3.8

mg/l

40.2

76.8

0.87

116

458

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

139

560

2.59

22.91

3.8

ratio

1.4

2.8

0.70

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

127

491

2.69

22.73

3.2

2.3

84.3

90.1

1.87

122

466

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

431

2681

1.77

22.49

3.5

3.1

e6/l

2.7

1.4

2.07

212

1549

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

179

818

2.30

22.40

5.5

2.6

1.4

1.2

1.04

179

811

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.99

22.32

1.7

2.5

—

(3003181) Sodium [Moles/volume] in Urine

281

3.23

22.18

1.7

1.3

mmol/l

54.7

64.6

1.48

231

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

304

1708

1.92

21.98

1.9

1.6

—

(3011412) CD3 cells [#/volume] in Blood

141

4.21

21.78

1.7

2.4

e9/l

1.1

1.0

0.29

(3021440) Promyelocytes/100 leukocytes in Blood

239

1244

2.05

21.50

5.1

4.2

0.1

0.17

126

386

(40760888) Immunoglobulin light chains.free panel - Serum

115

435

2.74

21.47

3.7

4.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

200

979

2.16

21.15

1.6

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

444

2830

1.73

21.12

3.2

2.9

e6/l

1.4

0.9

1.30

221

1692

(4198724)

7.14

20.80

1.8

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

7.24

20.37

2.5

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

162

3.85

20.34

3.5

3.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

119

4.37

20.20

2.6

1.5

promille

1.2

0.11

(3004588) Protein electrophoresis panel - Serum or Plasma

230

1208

2.02

20.14

3.1

2.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

4.73

20.13

1.5

1.3

u/ml

2.6

0.7

0.72

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

108

409

2.73

20.12

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

221

3.39

20.05

1.5

1.7

g/l

0.7

0.9

0.75

171

(3011288) Drugs identified in Urine by Screen method

233

3.30

19.78

5.8

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

109

419

2.69

19.73

1.4

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

173

823

2.21

19.62

1.4

1.3

u/ml

443.9

259.5

0.44

161

757

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

700

5084

1.58

19.61

4.0

3.1

ng/l

2080.6

1690.0

1.32

637

4390

(3047181) Lactate [Moles/volume] in Blood

132

561

2.45

19.43

11.7

6.9

mmol/l

1.2

1.3

0.78

115

490

(3001122) Ferritin [Mass/volume] in Serum or Plasma

826

6254

1.54

19.09

3.9

2.8

ug/l

209.4

162.9

3.15

775

5729

(4035726)

246

1348

1.94

19.03

1.5

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

313

2.93

19.03

3.7

3.6

60.0

58.4

0.45

313

(1175426) CD3 cells/100 lymphocytes in Blood

108

4.43

18.99

1.6

2.4

71.0

71.1

0.01

101

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

147

663

2.31

18.94

2.7

2.6

g/l

4.0

3.9

0.30

104

488

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

147

664

2.31

18.87

2.7

2.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

147

665

2.31

18.80

2.7

2.6

g/l

8.2

7.3

3.78

105

509

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

105

4.46

18.75

1.5

2.5

17.0

15.3

0.24

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1313

15005

0.64

18.66

4.5

mmol/l

1.4

0.41

1196

13757

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

173

3.60

18.52

1.5

1.9

—

(3036489) Thrombin time

135

598

2.35

18.12

2.9

2.1

22.1

21.7

0.33

125

533

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

682

4997

1.55

18.03

2.8

2.2

u/l

221.7

250.3

0.35

649

4695

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

103

403

2.64

18.01

1.9

2.0

mg/l

12.8

11.3

0.79

367

(3019309) Folate [Moles/volume] in Red Blood Cells

476

3209

1.63

17.93

2.1

1.8

nmol/l

1221.4

1160.0

0.68

389

2432

(1001926) Buprenorphine [Presence] in Urine by Screen method

285

2.96

17.92

4.1

2.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

138

621

2.31

17.87

2.8

2.6

g/l

10.5

0.06

114

527

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

187

3.45

17.86

1.5

1.8

—

(3025159) Blasts/100 leukocytes in Blood

217

1166

1.96

17.74

5.4

4.2

0.0

0.4

0.79

109

322

(3004809) Band form neutrophils/100 leukocytes in Blood

283

2.94

17.54

3.4

3.7

1.6

1.2

0.34

221

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

438

2913

1.64

17.35

4.1

3.2

mmol/l

2.5

2.4

6.84

380

2558

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

143

3.78

17.31

1.2

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

629

2.26

16.92

2.6

g/l

3.5

3.1

3.74

104

499

(3008757) Leukocyte morphology finding [Identifier] in Blood

195

3.30

16.74

3.4

4.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1340

15125

0.66

16.17

4.6

mmol/l

4.3

4.5

9.19

1229

13972

(3018572) Chloride [Moles/volume] in Blood

101

416

2.50

15.92

13.1

7.7

mmol/l

104.6

105.5

0.98

368

(3039000) Anion gap in Blood

101

416

2.50

15.92

13.1

7.7

mmol/l

10.6

11.5

1.90

368

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

209

1150

1.91

15.89

5.2

4.3

ng/l

113.7

100.6

0.79

189

1012

(3027273) Bicarbonate [Moles/volume] in Venous blood

169

865

2.04

15.81

5.0

3.3

mmol/l

25.6

25.1

0.97

164

834

(3009466) Valproate [Moles/volume] in Serum or Plasma

245

2.97

15.74

7.3

5.1

umol/l

378.7

356.7

0.63

220

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

103

4.14

15.65

1.8

2.4

e6/l

513.8

570.4

0.19

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

351

2.61

15.35

7.2

6.0

iu/ml

238.3

735.4

0.72

(3037522) Nuclear Ab [Titer] in Serum

299

1857

1.72

15.19

1.5

1.3

titre

424.2

471.8

0.28

385

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

414

2.46

15.11

2.1

1.3

g/l

0.2

0.11

395

(3016879) Cocaine [Presence] in Urine

337

2.62

15.02

4.7

2.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

535

3840

1.54

15.01

1.9

1.6

nmol/l

18.4

19.9

1.65

493

3294

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

124

575

2.23

14.96

2.9

2.7

g/l

0.3

1.3

4.81

104

502

(1761868) Lipid panel - Serum or Plasma

361

5245

0.62

14.77

3.1

3.0

—

(3022313) Gas panel - Capillary blood

164

861

1.98

14.29

7.5

4.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

153

3.39

14.27

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

153

3.39

14.27

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

153

3.39

14.27

1.5

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

119

555

2.22

14.16

11.1

4.1

mmol/l

3.9

4.0

1.24

113

513

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

428

2.38

14.07

2.2

1.3

g/l

1.1

1.2

1.64

406

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1389

15455

0.67

14.03

4.9

5.1

mmol/l

2.5

2.7

12.38

1262

14172

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

110

499

2.27

14.00

1.4

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

362

2.50

13.93

4.7

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

4.00

13.90

1.7

2.5

e9/l

0.3

0.2

0.24

(3027008) Opiates [Presence] in Urine

365

2.48

13.69

4.6

2.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

143

3.41

13.59

1.3

1.2

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1293

14553

0.69

13.55

4.3

4.1

mmol/l

1.3

0.48

1164

13263

(3028300) Cannabinoids [Presence] in Urine

367

2.46

13.54

5.0

2.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

132

653

2.09

13.53

2.0

1.9

u/l

36.8

38.1

0.38

117

572

(3007164) IgA [Mass/volume] in Serum or Plasma

389

2659

1.57

13.39

1.8

1.5

g/l

2.9

2.7

1.24

258

1646

(4010399)

195

1111

1.84

13.26

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

142

733

2.01

12.98

10.5

5.7

0.9

1.25

132

682

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

130

650

2.07

12.96

2.2

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

143

742

2.00

12.88

10.4

5.6

1.8

1.7

0.39

132

690

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

826

6611

1.42

12.84

2.5

2.0

pmol/l

88.1

92.5

2.24

512

3618

(3027944) Amphetamines [Presence] in Urine

360

2.42

12.66

4.9

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1303

11325

1.43

12.50

6.0

4.0

mm/h

25.3

12.5

55.13

1239

10444

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

108

510

2.18

12.49

2.5

g/l

0.0

1.42

101

468

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

102

472

2.22

12.40

2.5

g/l

0.0

0.00

436

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.53

12.12

1.4

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

102

477

2.20

12.09

2.5

g/l

0.0

0.00

437

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

136

710

1.98

12.04

2.5

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

744

5897

1.41

11.99

2.7

2.2

nmol/l

72.9

76.1

2.25

684

5218

(3037467) Urinalysis macro (dipstick) panel - Urine

1228

10616

1.40

11.78

5.6

4.2

—

(3052851) Hemolysis interference index of Serum or Plasma

102

486

2.16

11.55

5.1

3.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

108

529

2.10

11.39

2.5

2.4

g/l

34.0

37.4

6.08

459

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1219

0.36

11.28

1.7

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

536

6868

0.70

10.88

3.7

4.3

21.5

21.8

0.13

238

3379

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

793

6451

1.38

10.60

5.1

3.9

ng/l

45.9

63.2

0.94

641

4771

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

449

2.12

10.21

1.5

1.6

iu/ml

1.4

15.8

0.51

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.71

10.18

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

4.35

10.05

1.2

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

342

2408

1.51

10.05

25.1

27.4

inr

1.6

1.4

1.08

332

(3000093) Morphology [Interpretation] in Blood Narrative

161

2.90

10.04

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

448

3335

1.44

9.90

7.4

4.5

—

(3017704) Immunofixation for Urine

100

3.44

9.88

1.3

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

9.28

9.87

1.4

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

707

8564

0.73

9.83

4.4

5.0

ug/l

2.5

3.5

0.85

615

7676

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

276

1875

1.55

9.56

2.4

1.8

1.9

1.5

5.97

227

1616

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

244

1614

1.58

9.49

2.8

2.4

ug/l

8.1

7.3

0.28

216

1430

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

124

3.10

9.38

1.2

titre

238.6

138.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.56

9.35

15.5

9.7

mmol/l

4.8

6.3

1.62

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

370

4955

0.69

9.28

2.8

3.1

ug/l

0.7

0.8

1.12

261

3338

(3016038) Potassium [Moles/volume] in Urine

110

3.22

9.19

1.6

1.2

mmol/l

34.8

35.5

0.06

(3017354) Segmented neutrophils/100 leukocytes in Blood

175

2.73

9.18

2.4

3.8

62.5

55.7

1.12

118

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

3.16

8.93

2.1

2.2

e6/l

545.3

719.3

0.63

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

175

2.67

8.64

2.5

2.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.75

8.62

3.3

2.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.97

8.60

1.3

2.4

u/ml

484.4

36891.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

113

3.04

8.17

2.2

2.8

38.5

0.00

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.56

8.12

1.7

2.2

—

(3051651) Icteric interference index of Serum or Plasma

3.16

7.96

5.6

3.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

138

2.79

7.82

1.2

1.3

—

(3011648) Oxygen content in Venous blood

138

2.79

7.82

2.2

2.1

9.8

11.5

1.46

138

(40768797) Stomach Pathology biopsy report

290

2077

1.46

7.72

1.5

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

267

2.25

7.67

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

224

2.36

7.58

1.6

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

282

2.20

7.54

1.8

1.4

—

(3000492) Spirometry study

213

1439

1.54

7.53

1.7

1.5

—

(3044927) Protein electrophoresis panel - Urine

182

2.51

7.51

1.2

1.1

—

(40768804) Tissue Pathology biopsy report

712

5925

1.31

7.46

2.4

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

108

614

1.80

7.45

2.7

3.4

u/ml

277.5

6717.6

0.81

522

(21494890) Protein electrophoresis panel - 24 hour Urine

190

2.45

7.36

2.4

2.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

143

2.69

7.33

1.5

1.2

u/l

101.7

57.0

0.58

(21494814) CD8 cells/100 lymphocytes in Specimen

3.85

7.25

1.6

2.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

438

1.93

7.22

1.8

1.7

—

(21494755) Public health laboratory ask at order entry panel

1203

0.49

7.13

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

151

2.61

7.13

5.2

3.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

122

731

1.71

7.03

9.1

4.3

mmol/l

24.5

24.8

0.34

115

687

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.17

6.99

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.17

6.99

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.17

6.99

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.17

6.99

1.7

1.9

—

(4015189)

3.87

6.98

2.4

1.8

—

(3000012) Reticulocyte production index

3.24

6.98

1.3

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

1377

12555

1.31

6.97

45.6

19.1

14.5

13.8

55.08

1360

12268

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.02

6.93

3.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

6.03

6.90

1.1

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

13.82

6.89

1.2

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1384

14931

0.77

6.76

4.9

4.7

mmol/l

6.2

6.1

2.17

1256

13521

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.52

6.72

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.52

6.72

1.5

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.23

6.70

1.9

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

5.74

6.59

1.3

1.0

iu/ml

5.2

12.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.46

6.57

1.5

2.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.27

6.56

4.8

2.4

u/ml

892.3

1069.4

0.21

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1330

14403

0.77

6.55

6.7

6.1

mmol/mol

41.1

40.5

1.16

1220

13295

(3052592) Norovirus Ag [Presence] in Stool

4.85

6.45

1.5

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

190

1298

1.51

6.38

6.9

4.2

mmol/l

1.2

1.08

182

1135

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.24

6.29

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

103

2.84

6.27

2.4

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

360

1.95

6.25

3.2

3.1

nmol/l

0.8

0.9

0.33

279

(3000060) B lymphocytes [#/volume] in Blood

4.44

6.24

1.5

2.6

e6/l

116.3

227.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.24

6.01

1.2

1.4

umol/l

44.3

42.7

0.07

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

779

0.44

5.76

1.3

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

458

1.80

5.75

1.5

1.4

ug/g

210.1

269.3

1.85

280

(3039443) Prostate specific Ag panel - Serum or Plasma

475

0.29

5.72

1.6

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

436

3500

1.31

5.69

4.3

3.5

—

(3008295) Osmolality of Serum or Plasma

169

2.33

5.69

1.4

mosm/kgh2o

271.4

280.1

1.37

124

(3002256) Pathology report gross observation

272

2034

1.39

5.66

1.4

1.3

—

(3019977) pH of Arterial blood

2.78

5.63

4.0

3.1

7.4

0.16

(4306422)

215

2.17

5.62

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

3.55

5.60

1.2

2.2

—

(3004451) EKG impression Narrative

2.82

5.57

1.1

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

210

2.17

5.52

1.2

u/ml

2.7

5.5

1.52

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1633

15398

1.32

5.50

41.6

15.8

mg/l

49.1

26.6

72.48

1552

12396

(3035637) Corticotropin [Mass/volume] in Plasma

198

2.20

5.46

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

245

2.07

5.43

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

212

2.15

5.40

1.2

u/ml

1.5

4.4

1.11

(3021601) Nitrite [Presence] in Urine by Test strip

845

7400

1.24

5.35

6.0

4.8

estimate

0.0

0.00

194

1427

(3035350) Ketones [Presence] in Urine by Test strip

848

7434

1.24

5.31

4.6

3.6

estimate

0.0

0.00

190

1395

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.87

5.26

1.2

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1112

10050

1.24

5.21

4.8

3.2

u/l

78.3

56.2

6.50

1040

9340

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.81

5.14

2.0

1.6

u/l

1.1

8.3

2.22

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

251

2.02

5.10

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

852

7503

1.23

5.03

4.6

3.6

estimate

0.0

0.32

189

1339

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

10.04

5.02

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.80

5.01

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

206

2.11

4.97

4.3

7.9

mmol/l

8.2

7.3

0.58

174

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.75

4.94

2.3

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.68

4.92

3.3

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

133

1932

0.67

4.88

4.0

4.6

32.7

32.0

0.27

1294

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

313

1.88

4.83

1.8

1.5

—

(3017569) Oxygen content in Arterial blood

2.69

4.75

3.0

2.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

280

1.92

4.71

1.9

1.5

u/ml

222.7

122.7

0.46

(3044889) 12 lead EKG panel

1209

11104

1.22

4.55

5.1

4.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.61

4.48

1.2

—

(3021788) Differential panel - Synovial fluid

300

1.86

4.45

1.4

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

252

1.93

4.37

4.2

3.8

—

(40757373) Influenza virus identified in Isolate

3.35

4.32

1.4

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

955

8614

1.21

4.18

3.2

2.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

4.09

4.16

2.3

3.6

umol/l

39.8

46.4

0.67

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

308

1.81

4.12

1.2

1.3

miu/ml

184.3

216.8

0.24

126

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

216

1.96

4.07

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

180

1331

1.39

4.03

5.6

3.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

355

1.74

4.03

1.4

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

6.45

3.98

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

517

0.44

3.98

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.49

3.97

1.5

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.49

3.97

1.5

1.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.14

3.93

1.5

1.2

—

(4268621)

145

2.16

3.87

2.2

2.3

—

(3042517) Benzodiazepines panel - Urine

7.30

3.86

4.0

1.6

—

(40768446) Kidney Pathology biopsy report

2.69

3.82

1.6

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

8.78

3.77

1.0

—

(3044941) Cell count panel - Synovial fluid

267

1.82

3.71

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

105

714

1.50

3.70

3.2

3.3

pmol/l

4.2

4.5

2.21

626

(3034426) Prothrombin time (PT)

3.01

3.69

1.1

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.01

3.69

2.3

2.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

462

1.60

3.55

1.7

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

420

1.62

3.40

1.4

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

428

1.61

3.40

1.1

1.2

titre

91.4

95.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.67

3.39

2.4

3.1

umol/l

254.5

100.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.45

3.38

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.02

3.37

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.02

3.37

1.2

1.1

98.0

91.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

422

1.61

3.34

1.4

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.37

3.32

1.1

1.2

nmol/l

150.4

140.8

0.38

(42529406) Shigella sp [Presence] in Stool by Culture

426

1.59

3.23

1.4

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.58

3.19

1.0

1.2

—

(3037121) Protein [Mass/volume] in Urine

605

1.49

3.19

3.0

3.7

g/l

0.5

0.3

0.94

259

(3016750) Collection duration of Urine

104

2.23

3.16

2.7

2.1

min

505.8

493.0

0.14

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

276

1.72

3.08

1.4

1.1

u/ml

11.9

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

473

4095

1.20

3.02

5.4

3.9

estimate

0.0

0.69

170

1338

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

190

1.86

2.97

1.5

73.4

62.0

0.94

124

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

327

1.64

2.91

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.38

2.89

4.0

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.51

2.87

1.4

2.5

e6/l

688.8

917.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

167

1.87

2.72

1.3

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

241

1.72

2.71

1.1

g/l

1.7

1.5

1.10

221

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

338

2869

1.21

2.64

1.3

1.2

u/ml

2.8

1.7

0.33

754

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

168

1316

1.30

2.64

4.5

2.8

ml/min/173m2

61.0

63.6

0.27

536

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.56

2.61

3.9

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.56

2.61

3.9

2.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

100

2.11

2.59

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

315

1.60

2.56

1.6

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

5.47

2.54

13.8

5.4

—

(3036603) Volume of Urine

2.12

2.49

1.7

1.5

1433.9

1872.3

—

(4094501)

444

0.54

2.47

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

137

1.91

2.46

3.0

2.3

768.3

652.6

0.62

(3026493) Urate [Moles/volume] in Serum or Plasma

502

4443

1.17

2.45

3.8

2.9

umol/l

2285.5

5803.1

1.65

440

3836

(3042733) HLA Ab [Presence] in Serum

2.47

2.45

6.8

4.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.09

2.43

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.09

2.43

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

103

2.05

2.41

2.2

2.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

401

1.51

2.40

1.8

1.6

e6/l

23393.3

16619.4

0.42

288

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.62

2.36

5.9

6.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

363

1.53

2.34

1.5

1.1

u/ml

24.5

26.5

—

(3034770) Mitochondria Ab [Titer] in Serum

437

1.48

2.32

1.2

—

1470.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

148

1.84

2.29

1.1

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

508

0.58

2.28

1.7

mg/l

4.4

4.7

0.06

364

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

343

1.53

2.23

1.5

1.2

u/ml

2.9

4.8

0.49

(3020876) Protein [Mass/time] in 24 hour Urine

157

1.79

2.22

1.9

2.0

—

2.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

150

1.81

2.20

3.1

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.13

2.18

1.1

—

(3047189) Immunofixation for 24 hour Urine

2.03

2.16

1.9

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.03

2.16

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

338

1.52

2.15

1.5

1.2

u/ml

16.9

3.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.30

2.14

1.9

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

166

2044

0.80

2.14

14.0

7.6

—

(36660697) Celiac disease serology panel - Serum

130

1015

1.30

2.14

1.2

—

(3025941) Bacteria identified in Stool by Culture

104

787

1.34

2.13

1.4

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

576

5205

1.15

2.10

3.7

3.3

mmol/l

7.0

8.0

5.67

490

4349

(3044007) Cell count panel - Peritoneal fluid

2.46

2.10

1.2

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

603

0.64

2.07

1.1

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

309

1.53

2.07

1.4

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

229

1920

1.22

2.05

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

265

2255

1.20

2.04

1.3

1.2

iu/ml

36.3

34.8

0.07

690

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

286

1.55

2.04

1.3

u/ml

325.4

287.6

0.37

169

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.15

1.98

2.8

umol/l

30.7

31.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.97

1.93

1.8

umol/l

15.2

16.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

188

1.66

1.91

1.2

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

444

1.41

1.81

1.6

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

105

817

1.30

1.81

2.5

2.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

2.03

1.75

32.5

35.8

ug/l

6.7

7.3

0.47

(3044242) Glucose [Moles/volume] in Arterial blood

103

1.85

1.71

3.4

2.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

424

1.40

1.71

2.5

1.7

—

(3019150) Specific gravity of Urine by Refractometry

370

3288

1.15

1.70

5.6

3.9

kg/l

1.0

0.17

479

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

251

1.52

1.68

1.5

1.1

u/ml

28.0

31.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.81

1.65

1.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

126

1018

1.25

1.63

5.7

3.4

e9/l

5.0

4.2

1.64

791

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

387

3461

1.15

1.63

1.8

1.7

pmol/l

32919727.3

30129296.3

0.03

322

2871

(3010813) Leukocytes [#/volume] in Blood

1664

17032

0.87

1.62

54.0

22.9

e9/l

8.2

6.9

25.74

1623

16494

(3036525) Urea [Moles/time] in 24 hour Urine

3.58

1.61

1.8

3.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

1664

17030

0.87

1.61

54.3

23.0

g/l

124.5

136.6

135.19

1644

16732

(44816559) Phosphatidylethanol [Mass/volume] in Blood

287

1.47

1.60

1.4

—

(3003694) ABO and Rh group [Type] in Blood

450

4071

1.14

1.59

1.4

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

1664

17027

0.87

1.58

53.8

22.9

e12/l

4.2

4.5

85.65

1622

16493

(3035941) MCH [Entitic mass]

1664

17025

0.87

1.57

53.6

22.8

30.1

30.5

10.68

1643

16726

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.21

1.57

1.0

1.4

g/l

12.2

13.9

—

(3024731) MCV [Entitic volume]

1664

17024

0.87

1.56

53.7

22.8

91.5

91.3

0.81

1643

16728

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

322

1.44

1.56

1.4

1.2

u/l

44.4

43.9

0.01

280

(3043410) Blood group antigens tested for on Red Blood Cells

2.11

1.55

1.4

2.0

—

(3007461) Platelets [#/volume] in Blood

1664

17021

0.87

1.54

54.0

22.9

e9/l

275.1

239.5

42.38

1625

16547

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.43

1.53

1.4

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.34

1.52

1.4

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.60

1.51

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

1.51

0.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.86

1.50

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

428

1.37

1.47

1.3

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1644

16033

1.14

1.47

43.7

18.6

mmol/l

138.4

139.7

54.00

1621

15624

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.13

1.44

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.13

1.44

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.13

1.44

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.73

1.43

1.3

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.73

1.43

1.8

2.5

—

(3045716) Anion gap in Serum or Plasma

1.80

1.43

1.8

2.5

mmol/l

7.3

9.4

0.96

(3009871) Measles virus Ab [Titer] in Serum

2.31

1.43

1.4

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

141

1.64

1.41

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.26

1.40

4.3

7.0

—

(3002619) Bacteria identified in Specimen by Culture

2.42

1.39

1.6

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.20

1.37

2.1

2.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.61

1.36

2.0

2.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.95

1.36

1.0

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.95

1.36

4.0

2.5

u/field

0.4

0.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

619

1.29

1.36

1.5

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.84

1.35

2.0

2.4

—

(3038026) Centromere Ab [Units/volume] in Serum

120

1.67

1.34

1.3

1.1

u/ml

13.8

74.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

152

1.59

1.32

1.7

1.4

17.3

27.0

1.20

(3009542) Hematocrit [Volume Fraction] of Blood

1425

13815

1.11

1.31

41.0

16.8

37.0

40.0

24.92

947

9474

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

129

1539

0.83

1.30

1.5

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

1.30

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.10

1.30

1.2

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.10

1.30

7.1

3.3

—

(3004616) Nuclear Ab [Presence] in Serum

177

1.53

1.29

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.78

1.28

1.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.89

1.28

1.3

1.2

iu/ml

322.4

196.6

0.53

(3020491) Glucose [Moles/volume] in Blood

115

1.66

1.25

4.4

1.8

mmol/l

8.1

6.8

0.83

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.40

1.24

1.0

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1644

16077

1.12

1.24

43.7

18.7

mmol/l

4.0

0.09

1619

15646

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

188

1.50

1.21

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.17

1.21

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.17

1.21

1.5

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.73

1.21

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

803

1.23

1.19

2.4

2.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.71

1.17

1.1

—

(1002224) Polysomnography panel

600

0.74

1.17

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

190

1.48

1.16

1.4

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

1.73

1.15

9.0

17.4

—

(3016018) Differential panel - Cerebral spinal fluid

150

1.54

1.14

3.4

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.69

1.13

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.69

1.13

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.69

1.13

1.6

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.69

1.13

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1.69

1.13

1.3

2.9

umol/l

4.8

11.8

1.19

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

143

1.54

1.11

2.6

2.0

u/field

1.4

1.9

0.32

(40761535) Cells panel - Urine sediment

160

1383

1.17

1.11

3.9

3.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.97

1.11

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.67

1.10

1.6

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

337

0.68

1.06

3.6

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

216

0.60

1.04

2.5

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

187

1.45

1.03

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

187

1.45

1.03

1.4

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.28

1.03

2.0

2.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.64

1.03

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.64

1.03

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.64

1.03

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

146

1.51

1.03

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.06

1.03

2.3

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

188

1.44

1.01

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

395

1.30

1.01

2.4

1.9

—

(3008898) HLA-B27 [Presence]

426

0.72

1.01

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

139

1.52

1.00

1.4

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

197

1.43

1.00

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

189

1.43

0.99

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.97

0.0

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.97

0.0

2.9

—

(40768441) Liver Pathology biopsy report

108

1.58

0.96

1.4

1.5

—

(3012516) Albumin [Mass/volume] in Urine

533

4998

1.09

0.96

3.7

3.3

mg/l

953.9

294.8

1.73

395

3342

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

235

0.64

0.96

2.0

1.4

—

(4281824)

109

1.56

0.93

1.1

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

370

3998

0.91

0.93

1.7

mmol/l

1.5

1.4

0.35

319

3312

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.72

0.92

1.4

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.15

0.91

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

795

0.81

0.90

4.0

3.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

151

1.46

0.90

2.2

2.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.91

0.88

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.79

0.87

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

111

1.54

0.87

1.7

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.86

0.87

1.9

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.86

0.87

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

316

1.30

0.87

2.3

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.00

0.87

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.00

0.87

5.3

8.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

161

1.43

0.86

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

112

1.52

0.85

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.60

0.84

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.78

0.84

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.78

0.84

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.78

0.84

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

523

0.78

0.83

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.70

0.80

1.0

—

(3045414) Leukocytes [Presence] in Urine

651

0.81

0.79

2.4

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.67

0.78

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

174

1.38

0.76

1.2

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

157

1.41

0.76

1.2

nmol/l

1.6

1.4

0.33

144

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

582

0.80

0.76

1.5

1.8

nmol/l

44.3

39.1

0.66

558

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.77

0.76

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

771

1.18

0.76

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.65

0.75

1.4

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.09

0.74

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

0.72

1.0

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

159

1.39

0.72

1.8

1.3

e6/l

312635.8

133008.5

0.29

110

(40768443) Skin Pathology biopsy report

656

1.18

0.70

1.5

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.93

0.70

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

213

1.32

0.68

2.9

2.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

187

1.34

0.68

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1003

0.86

0.68

1.5

1.4

—

(3011985) Renin [Units/volume] in Plasma

179

1.34

0.67

1.5

1.4

mu/l

130.2

68.8

0.37

159

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

603

5761

1.07

0.67

5.1

3.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

0.67

1.0

1.1

—

(4024509)

129

0.62

0.64

2.0

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

423

4001

1.07

0.63

4.7

3.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

190

1.32

0.62

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.52

0.62

2.6

3.2

u/l

181.6

206.3

0.80

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

121

1.41

0.62

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.64

0.62

1.0

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

217

1.29

0.61

2.9

2.5

mmol/l

104.0

105.5

0.74

212

(3041354) Potassium [Moles/volume] in Venous blood

217

1.29

0.61

2.9

2.5

mmol/l

4.0

4.1

0.34

212

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1110

0.88

0.61

1.7

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

191

1.31

0.61

2.1

2.3

u/l

6892.4

2234.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

139

0.65

0.60

2.2

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.60

0.0

1.0

—

40.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.57

0.60

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.59

1.0

1.1

—

(3024932) HLA-DR beta [Type]

1.54

0.59

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

246

1.26

0.58

1.6

—

(3024471) HLA-A [Type]

1.48

0.57

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.48

0.57

1.3

1.1

—

(3025130) Human papilloma virus identified in Specimen

1.48

0.57

2.6

1.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.67

0.56

1.2

1.7

pmol/l

14.3

13.5

—

(3013637) Mi-2 Ab [Presence] in Serum

1.67

0.56

1.5

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.67

0.56

1.5

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.67

0.56

1.0

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.67

0.56

1.5

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.67

0.56

1.5

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

303

1.23

0.54

2.8

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

451

1.18

0.53

3.1

2.3

ug/min

370.2

104.1

1.25

284

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.45

0.53

1.4

2.2

ug/l

20.8

146.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

415

1.19

0.52

1.6

1.7

—

(3045142) Bone marrow Pathology biopsy report

198

1.27

0.49

1.6

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

106

959

1.11

0.46

4.5

3.0

e6/l

0.8

0.3

0.89

106

939

(4034850)

494

0.85

0.46

22.9

10.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

895

0.89

0.45

1.3

—

60.0

—

(3013512) EKG study

497

4780

1.05

0.45

4.8

4.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

165

1.28

0.45

1.7

1.4

pmol/l

268.5

277.3

0.05

129

(3006270) Folate [Moles/volume] in Blood

141

0.71

0.44

1.1

1.2

nmol/l

328.6

367.3

—

119

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

368

1.17

0.43

3.3

3.7

u/ml

1781.3

947.5

0.19

345

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.61

0.43

6.0

4.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.56

0.42

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

295

1.19

0.41

1.2

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3001729) Color of Synovial fluid

0.00

0.41

0.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.3

—

744.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1109

10885

1.04

0.40

4.0

3.5

pmol/l

14.8

14.9

0.33

1008

9776

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

988

0.91

0.38

2.3

2.4

—

22.3

—

(4133840)

1.39

0.38

1.2

—

(3012565) Volume of 24 hour Urine

1.35

0.38

2.8

2.7

1173.3

1835.4

1.84

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

235

0.81

0.37

1.5

1.4

—

(4027681)

0.62

0.35

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

348

1.15

0.35

2.3

1.7

nmol/l

0.8

0.11

293

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

200

0.80

0.34

2.8

2.3

mg/l

26.2

22.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

467

0.88

0.33

1.8

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

340

1.15

0.33

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.70

0.33

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.35

0.32

2.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.35

0.32

2.0

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

202

1.19

0.31

1.1

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.32

0.30

2.0

2.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1623

16361

0.96

0.30

18.8

10.7

u/l

27.8

27.6

0.06

1586

15764

(3023410) Appearance of Cerebral spinal fluid

147

1.23

0.30

4.3

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.33

0.30

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

372

1.13

0.30

7.3

3.6

mg/l

40.9

30.3

0.67

236

(3020682) Albumin/Creatinine [Ratio] in Urine

541

5271

1.04

0.28

4.4

4.1

mg/mmol

20.1

9.0

2.66

388

3487

(3023511) Choriogonadotropin [Units/volume] in Urine

103

1.26

0.28

1.7

1.3

—

(44813793)

1.30

0.28

1.2

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

346

1.13

0.27

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

205

1.17

0.27

1.1

—

13.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

159

1.20

0.26

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1458

14448

1.03

0.26

32.6

14.8

ml/min/173m2

80.3

78.2

2.52

1286

12017

(3013139) Helicobacter pylori Ag [Presence] in Stool

913

0.93

0.26

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.22

0.25

6.2

6.6

—

(3035933) Granulocytes/100 leukocytes in Blood

1.32

0.23

13.2

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.32

0.23

1.2

1.4

78.2

90.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.32

0.23

1.6

1.1

65.8

92.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.27

0.22

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

11.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

104

0.77

0.21

1.1

1.0

mg/l

325.5

298.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

105

0.76

0.21

1.1

mg/l

42.4

45.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.2

—

(3022621) pH of Urine by Test strip

995

0.94

0.20

4.5

2.9

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.20

0.0

1.1

—

0.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

111

0.81

0.20

2.3

1.5

g/l

0.9

1.0

—

111

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

165

1.15

0.19

1.3

nmol/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

377

1.09

0.18

1.5

1.4

u/l

11.9

8.1

0.69

302

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

763

0.94

0.17

1.1

1.2

iu/ml

99.7

146.8

0.35

268

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

291

1.10

0.17

1.8

iu/l

2.9

5.0

—

(3006462) Nitrate [Presence] in Urine

1.16

0.16

2.4

3.2

—

(40761511) CBC panel - Blood by Automated count

1599

15912

1.02

0.15

33.8

14.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

161

1664

0.96

0.15

2.0

2.3

nmol/l

12.1

13.1

0.82

134

1464

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

105

1007

1.05

0.15

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

221

2152

1.03

0.14

1.3

1.2

u/ml

24.0

12.1

0.73

827

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

900

1.05

0.14

1.9

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

161

1562

1.03

0.13

2.2

2.4

ug/g

215.1

158.3

0.82

133

1260

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1634

16407

0.98

0.13

41.1

18.5

umol/l

88.0

84.2

1.61

1634

16398

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

170

1.12

0.13

1.1

—

(3019225) pH of Specimen

164

1593

1.03

0.13

6.3

4.4

—

(3005570) Glucose [Moles/volume] in Urine

168

0.89

0.11

1.7

1.9

—

(4146454)

178

0.90

0.11

2.6

2.5

—

(40768793) Breast Pathology biopsy report

197

0.91

0.10

1.2

1.3

—

(3020650) Glucose [Presence] in Urine

1.09

0.09

1.2

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.04

0.09

1.0

1.1

—

7.0

—

(3048879) Bone marrow aspiration report

1.11

0.09

1.5

1.9

—

(21494434) Karyotype in Bone marrow

175

0.91

0.08

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.82

0.08

3.8

1.3

—

(40765096) Chromosome analysis panel by Banding

0.83

0.08

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.81

0.08

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.09

0.08

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

195

1.08

0.08

1.0

1.1

u/ml

4.4

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.86

0.07

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

327

0.95

0.07

3.0

1.4

e6/l

73.9

32.1

0.54

260

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

327

0.95

0.07

3.1

1.5

e6/l

2399.6

848.2

0.63

268

(4211845)

1.05

0.07

2.4

3.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1351

13557

0.99

0.07

5.0

4.2

mu/l

1.9

2.1

0.74

1238

12262

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.86

0.07

1.6

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.11

0.06

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.11

0.06

1.1

1.2

—

(3024263) Appearance of Synovial fluid

100

1.10

0.05

1.6

1.5

—

(3014271) Vancomycin [Susceptibility]

100

1.10

0.05

3.4

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

120

1.08

0.05

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

139

0.93

0.03

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

320

1.03

0.03

1.4

iu/l

21.3

26.3

0.48

262

(3002523) Influenza virus A Ag [Presence] in Specimen

211

1.04

0.03

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

212

1.04

0.02

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

431

1.02

0.02

3.9

4.3

—

(3003338) MCHC [Mass/volume]

1279

12807

1.00

0.02

49.5

20.3

g/l

328.6

333.1

47.78

1269

12687

(3022145) Colonoscopy Study observation

168

1672

1.01

0.01

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

174

1.03

0.00

1.0

1.1

u/ml

22.9

6.7

—

(3045424) Erythrocytes [Presence] in Urine

252

0.99

0.00

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

117

1.03

0.00

2.1

1.6

—

76.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

127

1.02

0.00

1.6

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

243

0.99

0.00

1.0

1.1

iu/ml

1.4

83.9

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

12.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.0

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

170

1.00

0.00

1.0

1.1

u/ml

4.5

2.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

569.7

—

(4038314)

0.00

0.0

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.93

0.00

1.5

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.92

0.00

1.0

1.2

—

0.1

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.3

—

74.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

3.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.8

—

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

24.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.94

0.00

1.1

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

3.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.95

0.00

1.4

1.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_NECROTIC and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_NECROTIC	3.883 [3.25, 4.64]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.033

During the follow-up period (1.1.1998 — 31.12.2019), 1239 out of 3243 females with J10_NECROTIC died.

Males

Parameter	HR [95% CI]	p-value
J10_NECROTIC	3.933 [3.44, 4.5]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3480 out of 7999 males with J10_NECROTIC died.

Mortality risk

Mortality risk for people of age

years, who have J10_NECROTIC.

N-year risk	Females	Males
1	0.415%	0.674%
5	2.186%	4.328%
10	5.092%	10.557%
15	9.762%	19.553%
20	15.875%	31.206%

Relationships between endpoints

↥

Index endpoint: J10_NECROTIC – Suppurative and necrotic conditions of lower respiratory tract

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Suppurative and necrotic conditions of lower respiratory tract

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints